As mentioned previously, the AFFF Firefighting Foam MDL is a consolidated lawsuit filed on behalf of individuals who were exposed to PFAS containing firefighting foam and developed health problems
doi: 10.3390/genes13050730
Weight loss can be a sensitive topic, and having professional support made the process feel less isolating and more manageable
Castellana M, Cignarelli A, Brescia F, Perrini S, Natalicchio A, Laviola L, Giorgino F: Efficacy and safety of GLP-1 receptor agonists as add-on to SGLT2 inhibitors in type 2 diabetes mellitus: A meta-analysis
11 Semaglutide, whose chemistry Novo Nordisk published in 2015 and which received FDA approval in December 2017 as Ozempic for type 2 diabetes, pushed the concept further
Basel: Karger (2012)